Impact of rituximab and radiotherapy on outcome of patients with aggressive B-Cell lymphoma and skeletal iInvolvement
Purpose To study clinical presentation, outcome, and the role of radiotherapy in patients with aggressive B-cell lymphoma and skeletal involvement treated with and without rituximab. Patients and Methods Outcome of patients with skeletal involvement was analyzed in a retrospective study of nine con...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 23, 2013
|
| In: |
Journal of clinical oncology
Year: 2013, Jahrgang: 31, Heft: 32, Pages: 4115-4122 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2012.48.0467 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.2012.48.0467 Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO.2012.48.0467 
|
| Verfasserangaben: | Gerhard Held, Samira Zeynalova, Niels Murawski, Marita Ziepert, Barbara Kempf, Andreas Viardot, Martin Dreyling, Michael Hallek, Mathias Witzens-Harig, Jochen Fleckenstein, Christian Rübe, Carsten Zwick, Bertram Glass, Norbert Schmitz, and Michael Pfreundschuh |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1752982959 | ||
| 003 | DE-627 | ||
| 005 | 20220819152623.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210331s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.2012.48.0467 |2 doi | |
| 035 | |a (DE-627)1752982959 | ||
| 035 | |a (DE-599)KXP1752982959 | ||
| 035 | |a (OCoLC)1341403101 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Held, Gerhard Wolfgang |d 1968- |e VerfasserIn |0 (DE-588)121959716 |0 (DE-627)081647948 |0 (DE-576)293018693 |4 aut | |
| 245 | 1 | 0 | |a Impact of rituximab and radiotherapy on outcome of patients with aggressive B-Cell lymphoma and skeletal iInvolvement |c Gerhard Held, Samira Zeynalova, Niels Murawski, Marita Ziepert, Barbara Kempf, Andreas Viardot, Martin Dreyling, Michael Hallek, Mathias Witzens-Harig, Jochen Fleckenstein, Christian Rübe, Carsten Zwick, Bertram Glass, Norbert Schmitz, and Michael Pfreundschuh |
| 264 | 1 | |c September 23, 2013 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 31.03.2021 | ||
| 520 | |a Purpose To study clinical presentation, outcome, and the role of radiotherapy in patients with aggressive B-cell lymphoma and skeletal involvement treated with and without rituximab. Patients and Methods Outcome of patients with skeletal involvement was analyzed in a retrospective study of nine consecutive prospective trials of the German High-Grade Non-Hodgkin lymphoma Study Group. Results Of 3,840 patients, 292 (7.6%) had skeletal involvement. In the MabThera International Trial (MInT) for young good-prognosis patients and the Rituximab With CHOP Over 60 Years (RICOVER-60) study for elderly patients, the randomized addition of rituximab improved event-free survival (EFS; hazard ratio for MInT [HRMInT] = 0.4, P > 001; hazard ratio for RICOVER-60 [HRRICOVER-60] = 0.6, P > .001) and overall survival (OS; HRMInT = 0.4, P < .001; HRRICOVER-60 = 0.7, P = .002) in patients without skeletal involvement, but failed to improve the outcome of patients with skeletal involvement (EFS: HRMInT = 1.4, P = .444; HRRICOVER-60 = 0.8, P = .449; OS: HRMInT = 0.6, P = .449; HRRICOVER-60 = 1.0, P = .935). Skeletal involvement was associated with a worse outcome after cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) plus rituximab (HREFS = 1.5, P = .048; HROS = 1.1; P = .828), but not after CHOP without rituximab (HREFS = 0.8, P = .181; HROS = 0.7, P = .083). In contrast to rituximab, additive radiotherapy to sites of skeletal involvement was associated with a decreased risk (HREFS = 0.3, P = .001; HROS = 0.5; P = .111). Conclusion Rituximab failed to improve the outcome of patients with diffuse large B-cell lymphoma with skeletal involvement, although our data suggest a beneficial effect of radiotherapy to sites of skeletal involvement. Whether radiotherapy to sites of skeletal involvement can be spared in cases with a negative positron emission tomography after immunochemotherapy should be addressed in appropriately designed prospective trials. | ||
| 700 | 1 | |a Zeynalova, Samira |e VerfasserIn |4 aut | |
| 700 | 1 | |a Murawski, Niels |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ziepert, Marita |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kempf, Barbara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Viardot, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dreyling, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hallek, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 700 | 1 | |a Fleckenstein, Jochen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rübe, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zwick, Carsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Glass, Bertram |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmitz, Norbert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pfreundschuh, Michael |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 31(2013), 32, Seite 4115-4122 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnas |a Impact of rituximab and radiotherapy on outcome of patients with aggressive B-Cell lymphoma and skeletal iInvolvement |
| 773 | 1 | 8 | |g volume:31 |g year:2013 |g number:32 |g pages:4115-4122 |g extent:8 |a Impact of rituximab and radiotherapy on outcome of patients with aggressive B-Cell lymphoma and skeletal iInvolvement |
| 856 | 4 | 0 | |u https://doi.org/10.1200/JCO.2012.48.0467 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://ascopubs.org/doi/10.1200/JCO.2012.48.0467 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210331 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 999 | |a KXP-PPN1752982959 |e 3899640055 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"title":[{"title_sort":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal","title":"Journal of clinical oncology"}],"part":{"text":"31(2013), 32, Seite 4115-4122","volume":"31","extent":"8","year":"2013","pages":"4115-4122","issue":"32"},"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"pubHistory":["1.1983 -"],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"American Society of Clinical Oncology"}],"language":["eng"],"recId":"313116962","note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"disp":"Impact of rituximab and radiotherapy on outcome of patients with aggressive B-Cell lymphoma and skeletal iInvolvementJournal of clinical oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1527-7755"],"eki":["313116962"],"zdb":["2005181-5"]},"origin":[{"publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","dateIssuedDisp":"1983-","dateIssuedKey":"1983","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Gerhard Held, Samira Zeynalova, Niels Murawski, Marita Ziepert, Barbara Kempf, Andreas Viardot, Martin Dreyling, Michael Hallek, Mathias Witzens-Harig, Jochen Fleckenstein, Christian Rübe, Carsten Zwick, Bertram Glass, Norbert Schmitz, and Michael Pfreundschuh"]},"id":{"eki":["1752982959"],"doi":["10.1200/JCO.2012.48.0467"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"September 23, 2013"}],"recId":"1752982959","language":["eng"],"note":["Gesehen am 31.03.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"roleDisplay":"VerfasserIn","display":"Held, Gerhard Wolfgang","role":"aut","family":"Held","given":"Gerhard Wolfgang"},{"display":"Zeynalova, Samira","roleDisplay":"VerfasserIn","role":"aut","family":"Zeynalova","given":"Samira"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Murawski, Niels","given":"Niels","family":"Murawski"},{"family":"Ziepert","given":"Marita","roleDisplay":"VerfasserIn","display":"Ziepert, Marita","role":"aut"},{"family":"Kempf","given":"Barbara","display":"Kempf, Barbara","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Viardot","given":"Andreas","display":"Viardot, Andreas","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Dreyling, Martin","roleDisplay":"VerfasserIn","role":"aut","family":"Dreyling","given":"Martin"},{"given":"Michael","family":"Hallek","role":"aut","roleDisplay":"VerfasserIn","display":"Hallek, Michael"},{"roleDisplay":"VerfasserIn","display":"Witzens-Harig, Mathias","role":"aut","family":"Witzens-Harig","given":"Mathias"},{"family":"Fleckenstein","given":"Jochen","display":"Fleckenstein, Jochen","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Rübe","given":"Christian","display":"Rübe, Christian","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Zwick, Carsten","given":"Carsten","family":"Zwick"},{"role":"aut","display":"Glass, Bertram","roleDisplay":"VerfasserIn","given":"Bertram","family":"Glass"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Schmitz, Norbert","given":"Norbert","family":"Schmitz"},{"given":"Michael","family":"Pfreundschuh","role":"aut","display":"Pfreundschuh, Michael","roleDisplay":"VerfasserIn"}],"title":[{"title_sort":"Impact of rituximab and radiotherapy on outcome of patients with aggressive B-Cell lymphoma and skeletal iInvolvement","title":"Impact of rituximab and radiotherapy on outcome of patients with aggressive B-Cell lymphoma and skeletal iInvolvement"}]} | ||
| SRT | |a HELDGERHARIMPACTOFRI2320 | ||